Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New combo pill for blood pressure and diabetes tested in healthy volunteers

NCT ID NCT07568652

First seen May 10, 2026 · Last updated May 18, 2026 · Updated 1 time

Summary

This early-stage study tested a new drug called HL1113 in 37 healthy adults to see how the body processes it. The drug is designed to treat high blood pressure and type 2 diabetes. Participants took the drug once and had their blood levels measured to compare the effects of taking the ingredients together versus separately. The goal was to gather safety and processing information, not to treat any disease.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HYPERTENSION are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Central Hospital

    Seoul, South Korea

Conditions

Explore the condition pages connected to this study.